Ann Clin Microbiol.
2022 Sep;25(3):73-78. 10.5145/ACM.2022.25.3.1.
EUCAST v.12.0 Review Focused on Changes
- Affiliations
-
- 1Department of Laboratory Medicine, Inje University College of Medicine, Busan, Korea
- KMID: 2533952
- DOI: http://doi.org/10.5145/ACM.2022.25.3.1
Abstract
- Clinical and Laboratory Standards Institute and European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint tables are commonly used as guidelines for the interpretation of antimicrobial susceptibility testing results. These are updated annually to reflect new and revised antimicrobial susceptibility breakpoints. EUCAST v.12.0, which was published in January 2022, presents updated meropenem-vaborbactam breakpoints for Enterobacterales and Pseudomonas aeruginosa. It also suggests new breakpoints of susceptibility to various antibiotics for Vibrio spp. Flow charts were updated for Streptococcus pneumoniae and Haemophilus influenzae, and the breakpoints for anaerobic bacteria were divided according to each species. Furthermore, recommendations were made for cases without antimicrobial susceptibility testing breakpoints and links to several rationale and guidance documents were provided for technical convenience.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
- Aminoglycoside Susceptibility Profiles of Enterobacter cloacae Isolates Harboring the aac(6')-Ib Gene
- Introduction to the Revised International Guidelines on Breakpoints for Antimicrobial Susceptibility Testing
- Performance of Modified-EUCAST Rapid Direct Antimicrobial Susceptibility Testing on Clinical Urine Samples
- European Committee on Antimicrobial Susceptibility Testing-Recommended Rapid Antimicrobial Susceptibility Testing of Escherichia coli, Klebsiella pneumoniae, and Staphylococcus aureus From Positive Blood Culture Bottles
